Quarter Period Statement Of Income

Noile-Immune Biotech Inc. - Filing #7270247

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Quarter period statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
84,051,000 JPY
71,491,000 JPY
Operating profit (loss)
-1,069,183,000 JPY
-775,391,000 JPY
Non-operating income
Interest income
560,000 JPY
44,000 JPY
Non-operating income
107,529,000 JPY
50,000 JPY
Non-operating expenses
Non-operating expenses
381,000 JPY
352,253,000 JPY
Ordinary profit (loss)
-962,035,000 JPY
-1,127,594,000 JPY
Profit (loss) before income taxes
-962,035,000 JPY
-1,127,594,000 JPY
Income taxes - current
2,420,000 JPY
2,420,000 JPY
Income taxes
2,420,000 JPY
2,420,000 JPY
Profit (loss)
-964,455,000 JPY
-964,455,000 JPY
-964,455,000 JPY
-1,130,014,000 JPY
-1,130,014,000 JPY
-1,130,014,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.